ライフサイエンスコーパス: biomicroscopy

1 8, and 72 hours after treatment by slit-lamp biomicroscopy.

2 oscopy, biometry, pachymetry, and ultrasound biomicroscopy.

3 edia thicknesses were measured by ultrasound biomicroscopy.

4 anterior segment examination with slit-lamp biomicroscopy.

5 rneas (3 +/- 0.4) quantified using slit lamp biomicroscopy.

6 Eyes were examined weekly by slit-lamp biomicroscopy.

7 ne, CRB1, and mutations using topography and biomicroscopy.

8 in the rabbit eye was graded with slit lamp biomicroscopy.

9 in a large family were examined by slit lamp biomicroscopy.

10 iac function using high-frequency ultrasound biomicroscopy.

11 rafts were evaluated clinically by slit lamp biomicroscopy.

12 Graft survival was evaluated by slit lamp biomicroscopy.

13 taract development by conventional slit-lamp biomicroscopy.

14 sure and for as long as 10 days by slit lamp biomicroscopy.

15 sion of cataracts was monitored by slit-lamp biomicroscopy.

16 best corrected visual acuity, and slit-lamp biomicroscopy.

17 , dilated fundus examination, and ultrasound biomicroscopy.

18 ptical coherence tomography and by slit-lamp biomicroscopy.

19 tography, spectral-domain OCT, and slit-lamp biomicroscopy.

20 and on clinical signs detected by slit-lamp biomicroscopy.

21 action, subjective refraction, and slit-lamp biomicroscopy.

22 n ultrasound biometry and handheld slit lamp biomicroscopy.

23 rmation that cannot be provided by slit-lamp biomicroscopy.

24 hinning and flow abnormalities undetected by biomicroscopy.

25 mechanism of AAC was confirmed by ultrasound biomicroscopy.

26 ion, indirect ophthalmoscopy, and ultrasound biomicroscopy.

27 tumor on clinical examination and ultrasound biomicroscopy.

28 assessed by ophthalmologists using slit-lamp biomicroscopy.

29 AC depth was measured using an ultrasound biomicroscopy.

30 s were observed, as determined by ultrasound biomicroscopy.

31 gated with an ultrahigh-frequency ultrasound biomicroscopy.

32 gic features not visible to the clinician on biomicroscopy.

33 igh-quality color photography and ultrasound biomicroscopy.

34 argin of each eye, confirmed with ultrasound biomicroscopy.

35 ion regarding macular edema than FA (77%) or biomicroscopy (76%).

36 sing standard ultrasonography and ultrasound biomicroscopy, a lack of a transillumination shadow, and

37 d degree of PEX was assessed using slit-lamp biomicroscopy after medical pupillary dilation.

38 r hyaloid membrane observed during slit-lamp biomicroscopy after posterior vitreous detachment and co

39 Ultrasound biomicroscopy allows longitudinal studies of tumor devel

40 ovement was significant compared with fundus biomicroscopy alone (P = 2.98(-8)).

41 Fundus biomicroscopy alone vs fundus biomicroscopy with the add

42 determined with stereomicroscopy, slit lamp biomicroscopy, alpha-smooth muscle actin (alphaSMA), fib

43 rafts were evaluated by ophthalmic slit-lamp biomicroscopy and analyzed by Kaplan-Meier survival curv

44 Ultrasound biomicroscopy and anterior segment optical coherence tom

45 d 72 hours and were re-examined by slit-lamp biomicroscopy and by indirect ophthalmoscopy.

46 Slit lamp biomicroscopy and corneal pachymetry were performed week

47 After slit-lamp biomicroscopy and corneal Scheimpflug imaging, the Desce

48 onducted ocular examinations using slit-lamp biomicroscopy and dilated fundoscopy.

49 phy (OCT) has become an important adjunct to biomicroscopy and fluorescein angiography.

50 thelial closure was monitored with slit lamp biomicroscopy and fluorescein staining, and corneal neov

51 Combined fundus biomicroscopy and foveal swept-source OCT scans improved

52 tance visual acuity, comprehensive slit-lamp biomicroscopy and fundoscopy.

53 d corrected (CDVA) distance visual acuities, biomicroscopy and fundus appearance, topography-derived

54 amage was assessed by stereoscopic slit-lamp biomicroscopy and fundus photography and by confocal sca

55 the AC cell response, evaluated by slit-lamp biomicroscopy and graded using a standard grading system

56 ate of the grafts was assessed clinically by biomicroscopy and histologically for 8 weeks postimplant

57 was determined by merging the findings from biomicroscopy and imaging modalities to generate the max

58 erent soft x-ray sources for applications in biomicroscopy and in chemical spectroscopy.

59 and 72 hours after injection using slit-lamp biomicroscopy and laser flare photometry.

60 ure, best corrected visual acuity, slit lamp biomicroscopy and medical history were obtained by anoth

61 Ultrasound biomicroscopy and more recently anterior segment optical

62 actous stages visually observed by slit lamp biomicroscopy and retroillumination photography.

63 al advances, including diagnostic ultrasound biomicroscopy and small-incision surgery with foldable,

64 oscopy, assessment of IOL centration, fundus biomicroscopy and spectral-domain optical coherence tomo

65 al and optic nerve structure included fundus biomicroscopy and stereophotography.

66 s of each patient were examined by slit-lamp biomicroscopy and white-light IVCM (Confoscan 4; Nidek T

67 At 24 and 72 hours, slit-lamp biomicroscopy (and additionally indirect ophthalmoscopy)

68 t, cumulative dose, Orlando stage (slit-lamp biomicroscopy), and serum concentrations of amiodarone a

69 ding best-corrected visual acuity, slit-lamp biomicroscopy, and a dilated fundus examination.

70 30 and 60 by means of the tonopen, slit-lamp biomicroscopy, and bead-based cytokine assays for TGF-be

71 or FECD and corneal edema by using slit-lamp biomicroscopy, and categorized as having clinically defi

72 ce were screened for cataract with slit lamp biomicroscopy, and dissected lenses were examined with d

73 ith examination under anesthesia, ultrasound biomicroscopy, and electroretinography (ERG) were perfor

74 ivo lens changes were monitored by slit lamp biomicroscopy, and enucleated lenses were examined under

75 efects by indirect ophthalmoscopy, slit-lamp biomicroscopy, and ERG to discover new spontaneous mutat

76 Flowmetry, wall strain analyses, biomicroscopy, and histology were completed.

77 ity (CDVA), cycloplegic refraction, slitlamp biomicroscopy, and keratometry (K).

78 easurement, ultrasound pachymetry, slit-lamp biomicroscopy, and laser scanning in vivo confocal micro

79 l acuity recorded in LogMAR units, slit-lamp biomicroscopy, and optical coherence tomography were ana

80 CT) was measured using histology, ultrasound biomicroscopy, and optical coherence tomography.

81 al coherence tomography (AS-OCT), ultrasound biomicroscopy, and other devices.

82 After maximal mydriasis, slit-lamp biomicroscopy, and photography, imaging of the anterior

83 heir ocular surface evaluated with slit-lamp biomicroscopy, and tear production quantified with the S

84 Modern imaging modalities such as ultrasound biomicroscopy, anterior segment optical coherence tomogr

85 Ultrasound biomicroscopy appears to be a valuable tool in confirmin

86 eyes in the study were examined by slit-lamp biomicroscopy at baseline and 6, 9, 24, 48, and 72 hours

87 All eyes were examined by slit-lamp biomicroscopy at baseline, 3, 6, 9, 24, 48, and 72 hours

88 disk hemorrhage was evaluated with slit lamp biomicroscopy at each clinic visit prior to and followin

89 ocular alignment, external eye examination, biomicroscopy, auto-refractometry, retinoscope in cyclop

90 To evaluate the accuracy of preoperative biomicroscopy (BM), ultrasonography (US), and spectral d

91 rt defects can be diagnosed using ultrasound biomicroscopy but not with the clinical ultrasound syste

92 22 of 32 SCD eyes (68.8%) had retinopathy on biomicroscopy, by UWFA 4 of 24 (16.7%) SCD eyes had peri

93 specular microscopy, gonioscopy, ultrasound biomicroscopy, central macular thickness, intraocular pr

94 ive errors and best-corrected visual acuity, biomicroscopy, color fundus photography, electroretinogr

95 Ultrasound biomicroscopy comparison of two infants with Lowe oculoc

96 Optical coherence tomography and ultrasound biomicroscopy confirmed the diagnosis of malignant glauc

97 Confocal biomicroscopy confirmed the host recellularization of th

98 Ultrasound biomicroscopy confirmed the presence of a 3.8 mm parieta

99 Smartphone ophthalmoscopy and biomicroscopy could not be used to examine the fundus an

100 mean maximum diameter detected by slit-lamp biomicroscopy (d(SL max) = 4.1 mm +/- 0.9 mm) and by imm

101 mean maximum diameter detected by slit-lamp biomicroscopy (d(SL max) = 4.1 mm 0.9 mm) and by immunof

102 Best-corrected visual acuity, slit-lamp biomicroscopy, dilated fundus examination, wide-field ph

103 Slit lamp biomicroscopy disclosed the clinical features of LCD in

104 rious times following injection by slit lamp biomicroscopy, electroretinography (ERG), bacterial and

105 assessed bacteriologically and by slit lamp biomicroscopy, electroretinography, histology, and infla

106 Ultrasound biomicroscopy, endoscopy, and contrast agents were used

107 eudophakic patients who underwent ultrasound biomicroscopy examination between May 2009 and February

108 ore pupil dilation as well as dilated fundus biomicroscopy examination.

109 normal in all of the study groups; slit lamp biomicroscopy examinations revealed that no cells or fib

110 The effectiveness of fundus biomicroscopy examinations, foveal swept-source OCT scan

111 phic and clinical characteristics, slit-lamp biomicroscopy findings, and dilated ophthalmoscopy resul

112 injection, tarsal abnormalities or any other biomicroscopy findings, and no corneal infiltrates obser

113 hotometry were consistent with the slit-lamp biomicroscopy flare findings up to grade 3+.

114 pared with untreated animals using slit-lamp biomicroscopy, flow cytometry, and ELISA.

115 best-corrected visual acuity (BCVA), fundus biomicroscopy, fluorescein angiography (FA), and SDOCT.

116 ased on best-corrected visual acuity, fundus biomicroscopy, fluorescein angiography, and OCT.

117 Corneal biomicroscopy, fluorescein test, digital tonometry.

118 All eyes were evaluated by slit-lamp biomicroscopy for inflammatory response at 3, 6, 9, 24,

119 xcellent diagnostic capability of ultrasound biomicroscopy for most CHDs.

120 evaluated over 8 weeks in a masked manner by biomicroscopy for signs of rejection.

121 considerable agreement with dilated retinal biomicroscopy for the grading of DR.

122 ding best-corrected visual acuity, slit-lamp biomicroscopy, fundoscopy, fundus autofluorescence, spec

123 its, anterior segment examination, slit-lamp biomicroscopy, fundus photography, spectral-domain OCT,

124 al examination was performed using slit-lamp biomicroscopy, funduscopy, and macular optical coherence

125 Biomicroscopy, funduscopy, Pentacam imaging, noncontact

126 and best-corrected visual acuity, slit-lamp biomicroscopy, Goldmann applanation tonometry, gonioscop

127 subjective refraction IOP, anterior segment biomicroscopy, gonioscopy, assessment of IOL centration,

128 and ocular examination, including slit-lamp biomicroscopy, gonioscopy, specular microscopy.

129 edulloblastoma formation, we used ultrasound biomicroscopy-guided in utero injection of a Shh-express

130 Ultrasound biomicroscopy has allowed us to elucidate the anatomic v

131 Ultrasound biomicroscopy has revolutionized the evaluation of the a

132 Ultrasound biomicroscopy has the advantage of being able to illustr

133 mpared throughout the course of infection by biomicroscopy, histology, electroretinography, and bacte

134 Infection courses were analyzed by biomicroscopy, histology, electroretinography, and quant

135 Ultrasound biomicroscopy imaged the entire ciliary body, anterior a

136 Ultrasonic biomicroscopy images of zebrafish eyes were obtained wit

137 nown survival using MetaMorph, a proprietary biomicroscopy imaging software.

138 thinning/atrophy was detected by ultrasound biomicroscopy in 15% of cases and focal angle closure in

139 tic misplacement was confirmed by ultrasound biomicroscopy in all suspected cases.

140 ic fundus photography (method 1) and dilated biomicroscopy in combination with optical coherence tomo

141 r hyaloid membrane observed during slit-lamp biomicroscopy in patients with posterior vitreous detach

142 presumed-healthy eyes diagnosed by slit-lamp biomicroscopy in the AWE group and phlyctenular keratiti

143 This review describes the role of ultrasound biomicroscopy in the measurement of the anatomic structu

144 e fibrillar layer may be imaged by slit-lamp biomicroscopy in vivo with significant positive correlat

145 e fibrillar layer may be imaged by slit-lamp biomicroscopy in vivo with significant positive correlat

146 FECD) and to image such changes by slit-lamp biomicroscopy in vivo.

147 ced FECD eyes and may be imaged by slit-lamp biomicroscopy in vivo.

148 tandardized examinations including slit-lamp biomicroscopy, indentation gonioscopy, intraocular press

149 th a small or large eyecup during ultrasound biomicroscopy, indentation with a gonioscopy lens, and s

150 Visual outcomes, slit lamp biomicroscopy, intraocular pressure (IOP), and posterior

151 view, best-corrected visual acuity, slitlamp biomicroscopy, intraocular pressure measurement, goniosc

152 t of best-corrected visual acuity, slit-lamp biomicroscopy, intraocular pressure measurement, indirec

153 Ultrasonic biomicroscopy is a potential new diagnostic modality for

154 fined as high-grade lens opacity observed by biomicroscopy judged to be the cause of a best-corrected

155 ; ophthalmic examination including slit-lamp biomicroscopy, noncontact tonometry, fundus photography,

156 Patients were evaluated with biomicroscopy, OCT and OCT angiography, fundus autofluor

157 t, Cochet-Bonnet esthesiometry, and confocal biomicroscopy of corneal sub-basal plexus (SBP).

158 ected visual acuity (BCVA), ophthalmological biomicroscopy of the anterior segment and fundus, struct

159 Clinical follow-up using biomicroscopy of the cornea was performed at days 2, 4,

160 Different approaches, including slit-lamp biomicroscopy, ophthalmoscopic examination, ultrasound b

161 ked grader, applanation tonometry, slit-lamp biomicroscopy, optic nerve evaluation, and A-scan ultras

162 The clinical outcome was monitored by biomicroscopy, optical coherence tomography, confocal mi

163 valuated for signs of rejection by slit lamp biomicroscopy over 8 weeks.

164 Intraoperative ultrasound biomicroscopy performed at the time of the right eye tub

165 Ultrasound biomicroscopy provides objective, high-resolution images

166 aphy measurements, endothelial cell density, biomicroscopy, refraction, and intraoperative and postop

167 Biomicroscopy revealed a new NVD in his right eye.

168 Ultrasound biomicroscopy revealed a partially cystic mass adjacent

169 Ultrasound biomicroscopy revealed bilateral supraciliary effusion.

170 Ultrasound biomicroscopy revealed ciliary body cysts in the left ey

171 The next day, slit lamp biomicroscopy revealed DLK manifested as diffuse granula

172 Slit-lamp biomicroscopy revealed IOL opacification.

173 ptical coherence tomography and stereoscopic biomicroscopy review.

174 ment are slit-lamp biomicroscopy, ultrasound biomicroscopy, scheimpflug imaging, phakometry, optical

175 of the diseased eyes diagnosed by slit-lamp biomicroscopy, SD-OCT detected abnormal changes in the P

176 tient presented with BCVA of 0,5 logMAR, and biomicroscopy showed a minimal IOL opacification.

177 Ultrasound biomicroscopy showed ciliary malrotation and effusion, s

178 Biomicroscopy showed conjunctival hyperaemia in the left

179 evaluation, visual acuity was hand movement, biomicroscopy showed pseudoexfoliation syndrome and a tr

180 Slit-lamp biomicroscopy showed refractile, polychromatic crystalli

181 Comparison was made between slit lamp biomicroscopy (SLB) and photographic grading.

182 d at a single follow-up visit with slit-lamp biomicroscopy (SLB), in vivo confocal microscopy (IVCM),

183 findings, including visual acuity, slit-lamp biomicroscopy, spectral-domain optical coherence tomogra

184 e was no evidence of macular edema by fundus biomicroscopy, stereo fundus photography, or OCT.

185 n and a cyclitic membrane seen on ultrasound biomicroscopy, targeted cryotherapy was performed.

186 On ultrasound biomicroscopy the anterior chamber structures were diffi

187 Compared to biomicroscopy, the sensitivity and specificity of smartp

188 All corneas were examined by using slit-lamp biomicroscopy to determine the severity of FECD versus n

189 A uveitis specialist used slit-lamp biomicroscopy to grade the AC cells on a scale of 0 to 4

190 or cataract, a high grade of lens opacity by biomicroscopy to which best-corrected visual acuity wors

191 on was performed clinically, with ultrasound biomicroscopy (UBM) and i-OCT and keratoplasty was comme

192 day imaging technologies such as ultrasound biomicroscopy (UBM) and more recently, anterior segment

193 facilitate this process, such as ultrasound biomicroscopy (UBM) and the anterior segment OCT (AS-OCT

194 asurements taken with Orbscan II, ultrasound biomicroscopy (UBM) and the Artemis-2 VHF (very-high-fre

195 Ultrasound biomicroscopy (UBM) demonstrated hypotrophy of the cilia

196 Ultrasound biomicroscopy (UBM) images of the anterior chamber were

197 We assessed the ultrasound biomicroscopy (UBM) parameters including anterior chambe

198 Ultrasound biomicroscopy (UBM) revealed scleral thickening with per

199 Ultrasound biomicroscopy (UBM) showed that the angle in the right e

200 We used ultrasound biomicroscopy (UBM) to evaluate phakic patients with a h

201 , we have initiated studies using ultrasound biomicroscopy (UBM) to evaluate the vessel wall thicknes

202 n supine and sitting positions by ultrasound biomicroscopy (UBM) with bag/balloon technology.

203 alitative parameters defined from ultrasound biomicroscopy (UBM), anterior segment optical coherence

204 The techniques covered are: ultrasound biomicroscopy (UBM), microSPECT, microPET, near infrared

205 By means of ultrasound biomicroscopy (UBM), thickened (720 / 700 micron) and de

206 Using in utero ultrasound biomicroscopy (UBM), we studied embryonic day (E) 10.5 t

207 mined in utero with 40- to 50-MHz ultrasound biomicroscopy (UBM)-Doppler, to determine onset of embry

208 c position was re-evaluated using ultrasound biomicroscopy (UBM).

209 All corneas were examined using slit-lamp biomicroscopy, ultrasonic pachymetry, and confocal micro

210 r imaging the anterior segment are slit-lamp biomicroscopy, ultrasound biomicroscopy, scheimpflug ima

211 lated slit-lamp anterior segment, and fundus biomicroscopy; ultrawide-field color fundus photography

212 Slit-lamp biomicroscopy, visual acuity, refraction, endothelial ce

213 e incidence of mild to moderate hyperemia by biomicroscopy was 18%, 24%, and 11%, respectively.

214 itus with mild diabetic retinopathy (MDR) on biomicroscopy was analyzed using a custom-built algorith

215 Ultrasound biomicroscopy was performed in 21 eyes of 17 monkeys.

216 Slit lamp biomicroscopy was performed throughout the period and th

217 Slit lamp biomicroscopy was used to evaluate the cornea and lens,

218 mography (OCT), infrared fundus imaging, and biomicroscopy were performed at baseline and at week 1,

219 Visual acuity assessment and slit-lamp biomicroscopy were performed weekly for 10 weeks, every

220 scan, retinoscopy, refraction, and slit-lamp biomicroscopy were performed.

221 photography, ultrasonography, and ultrasonic biomicroscopy were used to evaluate clinical response to

222 photography, ultrasonography, and ultrasonic biomicroscopy were used to locate and evaluate the exten

223 Eyes were examined by slit lamp biomicroscopy with fluorescein solution to assess epithe

224 Fundus biomicroscopy alone vs fundus biomicroscopy with the addition of foveal swept-source O